Strategic M&A Leverage Life Science Outsourcing's history of acquisitions such as J-Pac Medical and recent asset investments to position cross-sell opportunities in end-to-end manufacturing, packaging, sterilization and regulatory services for medical device and diagnostic customers seeking scale and integrated supply chains.

Expanded Capabilities Highlight the in-house end-to-end offerings including assembly, packaging, medical package testing, sterilization, and thermoforming as a single-source solution to reduce vendor complexity for mid-market medical device firms aiming to accelerate go-to-market timelines.

Growth Engine With leadership changes including a new CEO, and strategic partnerships, present LSO as a growth-focused partner capable of expanding geographic reach, increasing manufacturing assets, and scaling operations for rising demand in niche diagnostics and microfluidics.

Regulatory Agility Position LSO’s deep regulatory knowledge as a differentiator for customers navigating complex compliance, enabling faster product launches and risk mitigation across sterile, packaging and design services in regulated markets.

SMB to Scale Target mid-market medical device and life science firms in need of scalable manufacturing with financials in the 10M–25M range, offering a proven path from design through finished goods with risk-managed supply chain in a smaller, more agile organization.